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• The Revolve™ System (LifeCell Corporation, Bridgewater, NJ, USA) is an integrated, high volume fat processing system launched in the United States in 2013.
• In animal models, the fat processed using Revolve had fewer red blood cells, fatty acids and debris than fat processed using traditional methods of decantation or centrifugation. 2, 3 The Revolve system was associated with significantly greater fat graft retention compared to decantation and was similar to centrifugation. 2 • To our knowledge, there are no studies examining the impact of AFG techniques on operating room (OR) time or costs despite OR use contributing significantly to the total cost of patient care.
Presented 
Purpose
• The objective was to assess the impact of Revolve and centrifugation on OR time and costs through developing a budget impact model (BIM).
Methods
Perspective and Data Inputs:
• The BIM was developed from a hospital administrator's perspective.
• Data from the literature including two conference posters [4] [5] and a survey of surgeons (n=30) were used for the BIM.
• Data inputs and references are summarized in Table 1 .
• Rate of AFG was calculated by averaging the lowest and highest volumes and times reported in two posters [4] [5] for Revolve (n=127) and centrifugation (n=131), respectively ( Figures 1A-1C) . As shown in Figures 1A and 1B , Revolve was associated with substantially greater volume of fat grafted and faster grafting time than centrifugation.
• Cost of OR included staff wages and facility costs. Both Canadian and US costs 6, 7 were averaged after converting Canadian dollars to USD and adjusting for inflation to 2014 USD. 8 • List price of Revolve was used for the BIM and the cost of centrifugation was considered to have depreciated over time, resulting in approximately $10 per procedure. Base Case:
• Mean volume of fat grafted per AFG was estimated to be 150mL based on a surgeon survey (n=30) [data not shown].
• Mean time of completing AFG for 150mL of fat was estimated by dividing 150mL by the rate of AFG from Figure 1C .
• A hospital was assumed to perform approximately 100 AFG procedures per year. This field as well as all other fields is modifiable in the interactive BIM.
Results
Base Case:
• Mean time to grafting 150mL of fat was substantially faster using Revolve than centrifugation: 29.1 minutes versus 116.1 minutes (range: 25.1-32.0 versus 104.1-125.8 minutes, respectively) (Figure 2 ).
• Mean cost of OR use per AFG procedure was substantially less with Revolve than centrifugation: $1,350 versus $3,424 (range: $1,233-$1,436 versus $3,072-$3,710, respectively) (Figure 3 ).
• The difference in annualized cost of OR use was as high as $207,476 between Revolve and centrifugation, signifying a substantial cost savings when converting from centrifugation to Revolve (Figure 4 ).
• Based on linear projection, cost savings as high as $622,429 are expected over three years if AFG procedures are performed using Revolve versus centrifugation (Figure 4 ).
• These results, however, should be interpreted as savings in opportunity cost of surgical staff more so than as absolute cost savings for individual hospitals.
Sensitivity Analysis:
• Breakeven threshold for volume of fat grafted was projected to be 28mL, indicating positive cost savings for Revolve versus centrifugation for any grafted fat volume >28mL.
• The equipment cost of Revolve can be as high as $2,579 before losing its potential cost savings when compared to centrifugation.
• Breakeven threshold for OR cost per minute was estimated to be $5.57, which was determined to be unrealistically low.
Limitations

Conclusions
References
• The current BIM applied conversions from rate of AFG to procedure time to OR costs. Variations in patient subgroups or geographic location of hospitals were not considered.
• Learning curve or comfort level of utilizing aforementioned AFG techniques was not considered in the BIM.
• Data inputs from the two conference posters [4] [5] were specific to women undergoing breast reconstruction. Rate of AFG from additional types of reconstructive or aesthetic surgeries such as face, neck, hands or buttocks is required to further test the impact of Revolve versus centrifugation on OR time and cost.
• As popularity of AFG increases, evaluating the economic impact of AFG systems becomes essential. Based on current findings, the Revolve system results in substantial OR time and cost savings compared to centrifugation, as much as $207,476 per 100 AFG procedures.
• Mean cost of OR use per AFG procedure was estimated by multiplying the time of grafting 150mL of fat by the mean cost of OR use and adding the equipment cost for Revolve and centrifugation, respectively.
• The difference between Revolve and centrifugation (cost of OR use per AFG procedure for Revolve subtracted from that of centrifugation) represented potential cost savings if a hospital converted from centrifugation to Revolve.
• Annualized costs were estimated by multiplying the mean cost of OR use per AFG procedure in increments of 100 (i.e., per year) for Revolve and centrifugation, respectively.
• Breakeven thresholds were tested for volume of fat grafted, cost of techniques, and OR cost per minute. 
